Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Jorden David Emerson
Over the trailing 90 days, Jorden David Emerson (Director at Nuo Therapeutics, Inc.) traded $340K of stock (net buying $15K) in AURX, per 5 SEC Form 4 transactions.
- Role
- Director
- Companies
- AURX
- Window
- Trailing 90 days · 5 transactions · CIK 1313516
- Net activity
- +$15K ($177K bought · $163K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| AURX | Nuo Therapeutics, Inc. | 5 | $177K | $163K | $15K |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-30 | AURX | Sell | 160.9K | $163K | Payment of exercise price or tax liability by delivering securities |
| 2026-06-30 | AURX | Buy | 162.5K | $162K | Exercise or conversion of derivative security |
| 2026-06-30 | AURX | Sell | 162.5K | $0 | Exercise or conversion of derivative security |
| 2026-06-29 | AURX | Buy | 125.0K | $0 | Grant, award or other acquisition |
| 2026-06-05 | AURX | Buy | 13.2K | $15K | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Jorden's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.